The Weight of Cardiovascular Disease

Recruiting now

Conditions studied: Cardiovascular Diseases, Obesity

In brief

The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 12 months.

Key facts

Study ID

NCT06053645

Run by

Mayo Clinic

People needed

60

Starts

2024-04-22

Expected to finish

2026-07-01

Last updated by the study team

2025-10-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• BMI ≥30 kg/m2
• At least one of the following CVD: atrial fibrillation (AF), coronary artery disease (CAD), HFpEF (heart failure with preserved ejection fraction), HFrEF (heart failure with reduced ejection fraction), ACHD (adult congenital heart disease), or valvular heart disease
• Patients evaluated in the Cardiometabolic clinic
• Willingness to complete questionnaires/surveys
• Ability to complete monthly self-assessments at home

You may not qualify if…

• BMI <30 kg/m2
• Pregnancy or lactating women
• Hemodynamically unstable CVD
• Active malignancy
• Autoimmune or systemic inflammatory diseases
• Severe renal or hepatic failure
• Being considered unsafe to participate as determined by the study physician
• Taking medications affecting weight or energy intake/energy expenditure in the last 6 months, including weight loss medications, antipsychotic medications, or other medications as determined by the study NP or physician
• Patients with active psychosis, mania, or substance use disorders

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.